Medical Cannabis: Overview of Emerging Legal Issues and their Impact on the International Market

Chuck Menahem Kanafi Related Seminars and Products

Principal

kanafilaw

Ambassador Menahem (Chuck) Kanafi is an advocate and third-party neutral focusing on resolving cross-border commercial disputes with experience in India, the US, Israel, Africa and Germany. He studied law at the Hebrew University of Jerusalem and served as an Appellate Prosecutor and Senior Civil Law Counsel in government. Thereafter, Chuck embarked on a three-decades long diplomatic career including legal, political and UN functions, culminating with ambassadorial posts in Ghana, Eritrea and as Consul-General in South India.

Upon retirement from the Foreign Service, Chuck established himself in private collaborative legal practice concentrating on mediating disputes in international trade and legal aspects of the medical cannabis industry, specifically focusing on international commercial disputes. Chuck is admitted to practice in Israel and New York State and in Israel and maintains a presence in New York, Berlin and Tel Aviv. Chuck serves on the Advisory Boards of a number of educational ADR initiatives in India, has served as a judge in international mediation competitions, is a member of the International Committee of the International Cannabis Bar Association, and has moderated panels at their Cannabis Law Institute 2019.
 

Dr. Jayashree Mitra Related Seminars and Products

Shareholder

Carlton Fields, P.A.

Dr. Jayashree Mitra focuses on patent litigation, including Hatch-Waxman patent litigation. She represents clients in federal court and before the Patent Trial and Appeal Board and the International Trade Commission in a full range of patent litigation, including Hatch-Waxman actions, inter partes review, post-grant review proceedings, and trade secret disputes. She also advises clients in the cannabis industry and psychedelic industry on regulatory compliance, helping them align their IP strategies to comply with FDA and DEA regulations and guidance.

Jayashree is well known for her detailed understanding of the pharmaceutical, biotechnology, cannabis, psychedelics, and emerging technology sectors. A former neuropharmaceutical researcher at Yale University, Jayashree's technical knowledge extends to small molecules, protein therapeutics, protein conjugates, vaccines, injectables, biologics, and biosimilars, as well as blockchain and data privacy. She has particular insight into the science underlying innovative cannabis technology products and psychedelics. Her research in neuropharmacology at Yale specifically involved analyzing the effects of psychoactive substances on the developing brain.

She also has experience handling antitrust matters, as well as intellectual property due diligence and technology agreements for mergers, acquisitions, and other corporate transactions. She is recognized as a certified information privacy professional (CIPP/US) by the International Association of Privacy Professionals.

Jayashree engages in extensive pro bono work, including criminal appeals and death penalty cases.

Marie Sanchez Related Seminars and Products

Lawyer & Founder

Nooa Avocats

Marie Sanchez is a lawyer at the Bars of Paris and Quebec. After beginning her career in Singapore with a large pharmaceutical group, she worked for nearly 10 years in renowned international law firms before founding NOOA Avocats.

A specialist in regulatory and contractual aspects related to life sciences, she has also developed expertise in the field of therapeutic cannabis and well-being hemp. She regularly intervenes in the context of training courses as well as in conferences, in France and abroad.

She holds a Master II Professional in Health Industry Law from the University of Montpellier I as well as an ESSEC-Mannheim Executive MBA.

Alejandro Luna Related Seminars and Products

Partner

Olivares y Compañía S.C.

Alejandro Luna joined Olivares in 1996 and became a partner in 2005. He is instrumental in the IP Litigation, Regulatory and Administrative Litigation practices and Co-chair of the Life Sciences & Pharmaceutical law and industry group and also he coordinates the litigation department. Mr. Luna has been crucial to the heart of Mexico’s intellectual property legal system as one of the few true patent regulatory and administrative litigation experts in Mexico. He acts on behalf of his clients as an attorney, and a lobbyist.
He has participated in questioning the constitutionality of certain provisions of the Industrial Property Law and the Federal Copyright Law. He is also the sponsor of an important proposal to modify the system of litigation and enforcement of intellectual property rights in Mexico. 
He has incorporated regulation changes and lobbying which has resulted in precedent for patent linkage regulations and life terms of pipeline patents in Mexico. This work has resulted in US$ billions of protected revenues for the R&D pharmaceutical industry in Mexico. As a result of his involvement, he has been selected as the delegate to represent AMIIF, the industry association for R&D pharmaceutical companies who do business in Mexico, in the Trans-Pacific Partnership negotiations. 
His practice is not solely devoted to Life Sciences; he represents clients across a myriad of industries. He has successfully litigated exclusivity for pharmaceutical patents and pioneered administrative court actions to seek recognition of DPE rights, which are not specifically contemplated by Mexican laws.
His commitment to just and fair law extends to his overall promise of client satisfaction; he lobbies to change the law to allow for proper patent protection and best serve his clients. Mr. Luna is also the author of several articles on patents, litigation and regulatory issues. He is a part-time professor at the Universidad Nacional Autonoma de México (UNAM).